The testing is through Labdoor, which isnt a major third-party certification, but Legion still gets a 4 out of 5 for its transparent labels and third-party testing
Future pharmaceutical CagriSema Anticipated FDA approval: Phase 3 trials completed FDA submission expected 2024-2025 Approval likely 2025-2026 Brand name: CagriSema Pharmaceutical pricing (projected): Likely $1,200-1,500/month without insurance Similar to Wegovy/Zepbound pricing Insurance coverage uncertain initially Patient assistance programs may be available Insurance considerations: May cover if BMI 30 with comorbidity Or BMI 27 with diabetes/hypertension Prior authorization required Step therapy (try semaglutide first) When pharmaceutical available: Easier administration (pre-filled pen likely) Medical support included Quality guaranteed Prescription required May or may not be cheaper than research peptides Troubleshooting CagriSema dosing issues Common problems and solutions
As water is forced through them under high pressure, that air is released into the water
Kabesch M, Hoefler C, Carr D, Leupold W, Weiland SK, von Mutius E
Nobodys checking PubMed before posting
This distinction is critical